| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Oct 29, 2025 | Neumora Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +1,915,700 | 6.00% | ✗ | $5M |
| Apr 2, 2024 | Apr 4, 2024 | Boundless Bio, Inc. | 10% Owner | Buy | 100.0 | +200,000 | 12.01% | ✗ | $3.2M |
| Feb 8, 2024 | Feb 12, 2024 | Sana Biotechnology, Inc. | 10% Owner | Buy | 96.3 | +1,818,181 | 5.39% | ✗ | $10M |
| Sep 19, 2023 | Sep 20, 2023 | Neumora Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,500,000 | 70.62% | ✗ | $25.5M |
| Dec 22, 2020 | Dec 22, 2020 | 908 Devices Inc. | 10% Owner | Buy | 96.3 | +300,000 | 5.53% | ✗ | $6M |
| Oct 16, 2019 | Oct 18, 2019 | Vir Biotechnology, Inc. | 10% Owner | Buy | 100.0 | +1,000,000 | 100.00% | ✗ | $20M |
| Dec 11, 2017 | Dec 13, 2017 | Quanterix Corp | 10% Owner | Buy | 100.0 | +266,000 | 20.92% | ✗ | $4M |
| Nov 9, 2017 | Nov 13, 2017 | IMPINJ INC | Director | Buy | 65.0 | +4,000 | 0.29% | ✗ | $97.7K |
| Jun 15, 2015 | Jun 17, 2015 | Pulmatrix, Inc. | 10% Owner | Buy | 97.5 | +2,286,456 | 100.00% | ✗ | $500.2K |
| Oct 4, 2013 | Oct 7, 2013 | FATE THERAPEUTICS INC | 10% Owner | Buy | 100.0 | +961,780 | 63.63% | ✗ | $5.8M |